BIRC7 Antibody

說明書

中文名稱：

BIRC7兔多克隆抗體
貨號：

CSB-PA839300ESR2HU
規格：

￥440
圖片：
Western blot
All lanes: Baculoviral IAP repeat-containing protein 7 antibody at 6μg/ml + Hela whole cell lysate
Secondary
Goat polyclonal to rabbit IgG at 1/10000 dilution
Predicted band size: 33, 31 kDa
Observed band size: 33 kDa
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) BIRC7 Polyclonal antibody
Uniprot No.：

Q96CA5
基因名：

BIRC7
別名：

Baculoviral IAP repeat containing 7 antibody; Baculoviral IAP repeat containing protein 7 antibody; Baculoviral IAP repeat-containing protein 7 antibody; BIRC 7 antibody; birc7 antibody; BIRC7_HUMAN antibody; KIAP antibody; Kidney inhibitor of apoptosis protein antibody; Livin antibody; Livin inhibitor of apotosis antibody; Melanoma inhibitor of apoptosis protein antibody; ML IAP antibody; ML-IAP antibody; MLIAP antibody; RING finger protein 50 antibody; RNF 50 antibody; RNF50 antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human Baculoviral IAP repeat-containing protein 7 protein (1-265AA)
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

Antigen Affinity Purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
產品提供形式：

Liquid
應用范圍：

ELISA, WB

推薦稀釋比：

Application	Recommended Dilution
WB	1:200-1:1000

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Apoptotic regulator capable of exerting proapoptotic and anti-apoptotic activities and plays crucial roles in apoptosis, cell proliferation, and cell cycle control. Its anti-apoptotic activity is mediated through the inhibition of CASP3, CASP7 and CASP9, as well as by its E3 ubiquitin-protein ligase activity. As it is a weak caspase inhibitor, its anti-apoptotic activity is thought to be due to its ability to ubiquitinate DIABLO/SMAC targeting it for degradation thereby promoting cell survival. May contribute to caspase inhibition, by blocking the ability of DIABLO/SMAC to disrupt XIAP/BIRC4-caspase interactions. Protects against apoptosis induced by TNF or by chemical agents such as adriamycin, etoposide or staurosporine. Suppression of apoptosis is mediated by activation of MAPK8/JNK1, and possibly also of MAPK9/JNK2. This activation depends on TAB1 and NR2C2/TAK1. In vitro, inhibits CASP3 and proteolytic activation of pro-CASP9. Isoform 1 blocks staurosporine-induced apoptosis. Isoform 2 blocks etoposide-induced apoptosis. Isoform 2 protects against natural killer (NK) cell killing whereas isoform 1 augments killing.
基因功能參考文獻：
1. The overexpression of PTEN concomitant with Livin gene silencing was confirmed as a feasible and effective in vitro and in vivo gene modulation method, which may represent a potential therapeutic strategy for the treatment of Gastric Cancer. PMID: 29436592
2. Livin overexpression not only significantly inhibited RCC cell apoptosis and increased cell viability, but completely reversed the si-CCAT1-mediated repression of cell viability PMID: 28470345
3. our results revealed that Livin induced EMT through the activation of the p38/GSK3beta pathway, which in turn promoted the progression and metastasis of breast cancer, especially for triple-negative breast cancer (TNBC) PMID: 29039608
4. our results suggest that siRNA-mediated Livin knockdown enhanced the chemosensitivity of the three head and neck squamous cell carcinoma cell lines to cisplatin, 5-FU and docetaxel. PMID: 28440463
5. Livin is specifically over-expressed in adrenocortical carcinoma. PMID: 28030838
6. Further experiments confirmed the induction of cell apoptosis and suppression of cell proliferation by anti-MM scFv-tP in LiBr cells, along with efficient silence of Livin gene both in vitro and in vivo. Altogether, our findings provide a feasible approach to transport Livin small interfering RNA to malignant melanoma cells which would be a new therapeutic strategy for combating malignant melanoma PMID: 28459204
7. MicroRNA-214 inhibits the osteogenic differentiation of human osteoblasts through the direct regulation of BIRC7. PMID: 28109866
8. the results of the present study suggested that Livin may enhance tumorigenesis by modulating the mitogenactivated/Akt signaling pathways in human HSCC. PMID: 27175933
9. Positive BIRC7 expression and negative KLF4 expression are associated with the progression of PDAC and poor prognosis in patients with PDAC. PMID: 27802195
10. High expression of BIRC7 is associated with drug resistance in Renal cell carcinoma. PMID: 27677286
11. Data show that cylindromatosis (CYLD) overexpression and livin knockdown might improve gemcitabine chemosensitivity by decreasing autophagy and increasing apoptosis in bladder cancer (BCa) cells. PMID: 27448305
12. The apoptosisinducing effects of livin and surivin knockdown were investigated using a Hoechst staining kit. PMID: 26708654
13. Expression of livin, survivin and caspase-3 are closely related to the occurrence and development of prostatic cancer. PMID: 26823716
14. Our results suggested the important role of Livin and its partner molecule in the process of VSV treatment PMID: 26412467
15. Data showed that Livin knock-down suppressed cell proliferation and inhibited cell invasion, accompanied by downregulation of VEGF and MMP-2/-9. Its silencing resulted in the prevention of xenograft tumor formation. PMID: 26094984
16. These findings suggest that livin may be used as a novel target for tumor gene therapy. PMID: 25695324
17. Upregulation of Livin expression and downregulation of caspase activity are observed under cycling and chronic hypoxia in glioblastoma cells and xenografts. PMID: 25370472
18. Livin expression was higher in condyloma acuminatum than in normal cells and was correlated with survivin and Ki-67. PMID: 26122233
19. Livin gene has a high expression in osteosarcoma and inhibits apoptosis in tumor tissue. PMID: 25374170
20. livin is associated with invasive and oncogenic phenotypes such as tumor cell invasion, tumor cell migration, tumor cell proliferation, and resistance to apoptosis in human oral squamous cell carcinoma cells. PMID: 25242075
21. These data suggest that livin overexpression plays an important role in tumor invasiveness by mediating resistance to apoptosis. PMID: 25339450
22. effectively silence Livin gene expression in LoVo colon cancer cells, inhibit cell proliferation and colony formation, induce apoptosis, and enhance sensitivity to cisplatin PMID: 24938471
23. In diagnostically difficult cases of diffuse large B-cell lymphoma and Hodgkin lymphoma, focus on livin as marker may provide useful corroborative information. PMID: 24767895
24. Low livin expression is associated with childhood acute lymphoblastic leukemia. PMID: 24696218
25. Co-silencing of Livin and Survivin can effectively inhibit the cell proliferation and apoptosis of lung cancer cells. PMID: 25261663
26. Livin expression was not associated with survival in pancreas ductal adenocarcinoma. PMID: 25090821
27. our findings indicate that the expression of Livin is increased in human GC and correlates with tumor differentiation and lymph node metastases PMID: 24220265
28. The expression of Livin was was independently related to survival in rectal cancer patients PMID: 24295240
29. Livin expression was positively correlated with the proliferation marker Ki-67, but was negatively correlated with caspase-3 expression in human ampullary carcinoma patients. PMID: 23343959
30. Data suggest that Livin has a role in thrombopoiesis by regulating the apoptotic and antiapoptotic balance in MK endoreplication and platelet production. PMID: 24287698
31. High livin expression is associated with lymph node micrometastasis in non-small cell lung cancer. PMID: 23404657
32. no significant correlation was found between Livin expression and various clinicopathological parameters including survival. PMID: 24008725
33. Livin is associated with tumor progression by increasing tumor cell motility and inhibiting apoptosis in colorectal cancer PMID: 24023847
34. our data suggest that Livin is involved in tumorigenesis of human osteosarcoma and may serve as a promising therapeutic target for osteosarcoma. PMID: 23632777
35. Livin interaction with caspase-3 and Livin role in the regulation of cell death PMID: 23563149
36. BRG1 regulates ML-IAP expression by cooperating with MITF to promote transcriptionally permissive chromatin structure on the ML-IAP promoter. PMID: 23480510
37. High BIRC7 expression is associated with lymph node metastasis in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. PMID: 23906305
38. Livin expression promotes breast cancer metastasis through the activation of AKT signaling and induction of EMT in breast cancer cells both in vitro and in vivo. PMID: 23524337
39. Livin may inhibit apoptosis in cervical squamous cell carcinoma by downregulating caspase-3, thereby promoting disease progression. PMID: 23781587
40. Genistein can suppress Livin gene expression, induce melanoma cell apoptosis, hinder the cell cycle, and restrain cell proliferation. PMID: 22931613
41. Survivin and livin mRNA levels in patients with lung cancer were significantly higher than in those with benign lung disease. PMID: 22930255
42. The increased expression of CD44v6 and Livin in gastric cancer tissue may be closely related with development and progression of gastric cancer. PMID: 22932199
43. Overexpression of Livin led to cisplatin resistance in colon cancer. PMID: 23188704
44. study demonstrated the expression of inhibitor of apoptosis proteins, survivin and Livin and the pro-apoptotic protein TSP-1 in endemic Burkitt lymphoma (BL); no significant difference was found between BL and reactive lymphoid hyperplasia PMID: 23030305
45. Livin expression may be regulated by miR-198 in human prostate cancer cell lines. PMID: 23069480
46. our data reveal a new, Livin-dependent, apoptotic role for TEAD1 in mammals and provide mechanistic insight downstream of TEAD1 deregulation in cancers. PMID: 23029054
47. study concludes PTEN and Livin are important in renal clear cell carcinoma development PMID: 22938441
48. data suggested that livin plays an important role in inhibiting the apoptosis of ovarian cancer cells PMID: 22766624
49. Bortezomib and arsenic trioxide can induce apoptosis by inhibiting the expression of livin mRNA in Jurkat cells. PMID: 21867610
50. Livin and survivin may be involved in the pathogenesis and progression of adult acute lymphoblastic leukemia. PMID: 21867615
顯示更多

收起更多
亞細胞定位：

Nucleus. Cytoplasm. Golgi apparatus. Note=Nuclear, and in a filamentous pattern throughout the cytoplasm. Full-length livin is detected exclusively in the cytoplasm, whereas the truncated form (tLivin) is found in the peri-nuclear region with marked localization to the Golgi apparatus; the accumulation of tLivin in the nucleus shows positive correlation with the increase in apoptosis.
蛋白家族：

IAP family
組織特異性：

Isoform 1 and isoform 2 are expressed at very low levels or not detectable in most adult tissues. Detected in adult heart, placenta, lung, lymph node, spleen and ovary, and in several carcinoma cell lines. Isoform 2 is detected in fetal kidney, heart and
數據庫鏈接：

HGNC: 13702

OMIM: 605737

KEGG: hsa:79444

STRING: 9606.ENSP00000217169

UniGene: Hs.256126

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human